Waldemar Debinski to Immunotherapy, Active
This is a "connection" page, showing publications Waldemar Debinski has written about Immunotherapy, Active.
Connection Strength
0.324
-
Mintz A, Gibo DM, Madhankumar AB, Cladel NM, Christensen ND, Debinski W. Protein- and DNA-based active immunotherapy targeting interleukin-13 receptor alpha2. Cancer Biother Radiopharm. 2008 Oct; 23(5):581-9.
Score: 0.324